1. Home
  2. CNVS vs SCYX Comparison

CNVS vs SCYX Comparison

Compare CNVS & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.25

Market Cap

56.6M

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$4.92

Market Cap

51.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNVS
SCYX
Founded
2000
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.6M
51.4M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
CNVS
SCYX
Price
$2.25
$4.92
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.00
$3.00
AVG Volume (30 Days)
132.6K
77.9K
Earning Date
02-17-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.36
EPS
N/A
N/A
Revenue
$65,733,000.00
$257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$84.42
$608.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.77
$0.57
52 Week High
$3.55
$6.09

Technical Indicators

Market Signals
Indicator
CNVS
SCYX
Relative Strength Index (RSI) 32.80 46.66
Support Level $1.93 $4.65
Resistance Level $2.26 $5.10
Average True Range (ATR) 0.10 0.34
MACD -0.03 -0.07
Stochastic Oscillator 4.35 1.68

Price Performance

Historical Comparison
CNVS
SCYX

About CNVS Cineverse Corp.

Cineverse Corp is a technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, and audio podcasts, Podcast, Media services, and Other non-recurring. Its brands include Hallmark, ITV, Nelvana, ZDF, Konami, NFL, and Highlander.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: